Answers are grounded in this paper and cite their sources.
Background and Objectives: This study presents a budget impact analysis (BIA) conducted in Saudi Arabia, evaluating the cost implications of adopting semaglutide, tirzepatide, or dulaglutide in the management of type 2 diabetes mellitus (T2DM) patients. The analysis aims to assess the individual budgetary impact of these treatment options on healthcare budgets and provide insights for decision-makers.
No takes yet. Share an insight, caveat, or question.
Al‐Omar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: